4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-22-033389
SVP, Chief Scientific Officer acquired 24,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Abrahmsen Lars B. SVP, Chief Scientific Officer | 2022-03-10 | Grant or award | +24,700 | 43,700 | D | ||
| Derivatives | |||||||
| Abrahmsen Lars B. SVP, Chief Scientific Officer | 2022-03-10 | Grant or award · Stock Option (right to Buy) | +100,000 | 100,000 | D | ||
Loading xslF345X03/tm229119-1_4seq1.xml…